login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
STRUCTURE THERAPEUTICS INC (GPCR) Stock News
USA
- NASDAQ:GPCR -
US86366E1064
-
ADR
26.18
USD
-0.74 (-2.75%)
Last: 10/22/2025, 12:24:05 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
GPCR Latest News, Press Relases and Analysis
All
Press Releases
a month ago - By: The Motley Fool
- Mentions:
LLY
This Under-the-Radar Healthcare Stock Could Soar in 2026
2 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences
3 months ago - By: Stocktwits
- Mentions:
LLY
VKTX
NVO
Eli Lilly Stock Marks Worst Day In 25 Years As Weight-Loss Pill Data Disappoints: Analysts Divided But Retail Bets On Rebound
3 months ago - By: Benzinga
- Mentions:
LLY
NVO
VKTX
TERN
Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors
3 months ago - By: Investor's Business Daily
- Mentions:
LLY
NVO
VKTX
Lilly Skids On A Shocking Obesity Setback. Novo, Viking, Structure Surge.
3 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
3 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
4 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671
8 months ago - By: The Motley Fool
Why Structure Therapeutics Stock Was Stumbling This Week
4 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671
5 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
6 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics Reports First Quarter 2025 Financial Results and Recent Highlights
6 months ago - By: Yahoo Finance
- Mentions:
TXN
LIVN
EWTX
IGT
...
Jim Cramer Applauds Texas Instruments (TXN): “Put Up Terrific Numbers”
6 months ago - By: Benzinga
- Mentions:
EVO
DLTR
IIIN
CAR
...
uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday
6 months ago - By: Stocktwits
- Mentions:
PFE
VKTX
JPM
Wall Street Sees Pfizer's Weight-Loss Pill Exit As A Win For 2 Smaller Biotech Firms: Retail Turns Bullish
6 months ago - By: Bloomberg
- Mentions:
PFE
VKTX
TERN
MTSR
Pfizer Setback Spurs Rise in Obesity Developers on M&A Hopes
8 months ago - By: Investor's Business Daily
- Mentions:
ABBV
LLY
NVO
VKTX
AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.
8 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights
9 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
9 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
10 months ago - By: Investor's Business Daily
- Mentions:
MRNA
ALNY
EXEL
CORT
...
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
10 months ago - By: Investor's Business Daily
- Mentions:
LLY
PFE
MRK
AZN
...
Merck Joins The Weight-Loss Race, Inking $2.01 Billion Deal To Take On Eli Lilly, Pfizer, Roche
10 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
10 months ago - By: Structure Therapeutics Inc.
Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
Please enable JavaScript to continue using this application.